Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Line Pickering

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Sleep Medicine|July 15, 2021
Diagnostic value of actigraphy in hypersomnolence disordersEva Wiberg Torstensen, Line Pickering, Birgitte Rahbek Kornum, et al.
Acta Paediatrica (Oslo, Norway : 1992)|August 25, 2021
Brain tumours in children and adolescents may affect the circadian rhythm and quality of lifeLine Pickering, Katharina M Main, Ulla Feldt-Rasmussen, et al.
Neurology and Therapy|February 11, 2026
Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER TrialPatricia Pozo-Rosich, Cristina Tassorelli, Line Pickering Boserup, et al.
Neurology and Therapy|January 18, 2024
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER StudyPatricia Pozo-Rosich, Messoud Ashina, Stewart J Tepper, et al.
Advances in Therapy|September 23, 2025
Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have FailedDimos D Mitsikostas, Susanne F Awad, Rikke Kongerslev, et al.
Sleep Medicine|October 29, 2021
Brain tumours result in sleep disorders in children and adolescentsLine Pickering, Katharina M Main, Astrid Sehested, et al.
Headache|November 6, 2024
Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trialAnna Gryglas-Dworak, Jack Schim, Anders Ettrup, et al.
Developmental Medicine and Child Neurology|December 1, 2022
Survival and long-term socioeconomic consequences of childhood and adolescent onset of brain tumoursLine Pickering, Katharina M Main, Ulla Feldt-Rasmussen, et al.
European Journal of Neurology|March 16, 2026
Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have FailedJessica Ailani, Messoud Ashina, Susanne F Awad, et al.
European Journal of Neurology|December 15, 2025
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER TrialCristina Tassorelli, Amaal J Starling, Susanne F Awad, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Sleep Medicine|July 15, 2021
Diagnostic value of actigraphy in hypersomnolence disordersEva Wiberg Torstensen, Line Pickering, Birgitte Rahbek Kornum, et al.
Acta Paediatrica (Oslo, Norway : 1992)|August 25, 2021
Brain tumours in children and adolescents may affect the circadian rhythm and quality of lifeLine Pickering, Katharina M Main, Ulla Feldt-Rasmussen, et al.
Neurology and Therapy|February 11, 2026
Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER TrialPatricia Pozo-Rosich, Cristina Tassorelli, Line Pickering Boserup, et al.
Neurology and Therapy|January 18, 2024
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER StudyPatricia Pozo-Rosich, Messoud Ashina, Stewart J Tepper, et al.
Advances in Therapy|September 23, 2025
Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have FailedDimos D Mitsikostas, Susanne F Awad, Rikke Kongerslev, et al.
Sleep Medicine|October 29, 2021
Brain tumours result in sleep disorders in children and adolescentsLine Pickering, Katharina M Main, Astrid Sehested, et al.
Headache|November 6, 2024
Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trialAnna Gryglas-Dworak, Jack Schim, Anders Ettrup, et al.
Developmental Medicine and Child Neurology|December 1, 2022
Survival and long-term socioeconomic consequences of childhood and adolescent onset of brain tumoursLine Pickering, Katharina M Main, Ulla Feldt-Rasmussen, et al.
European Journal of Neurology|March 16, 2026
Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have FailedJessica Ailani, Messoud Ashina, Susanne F Awad, et al.
European Journal of Neurology|December 15, 2025
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER TrialCristina Tassorelli, Amaal J Starling, Susanne F Awad, et al.
Pageof 3